| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/12/1994 | CA2105913A1 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions |
| 03/11/1994 | CA2105816A1 Substituted phenols, processes for their preparation and their use for the treatment of disorders caused by cell proliferation |
| 03/10/1994 | CA2105693A1 Benzopyran compounds, process for the preparation thereof and pharmaceutical compositions containing them |
| 03/10/1994 | CA2105612A1 Use of low doses of manganese superoxide dismutase (mn-sod) in the treatment of diseases |
| 03/09/1994 | EP0586344A1 Oxazolidene derivatives and their use as pharmaceuticals |
| 03/09/1994 | EP0585963A1 Monoclonal antibodies to CMP-170 antigen on activated endothelial cells |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585681A2 Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections |
| 03/09/1994 | EP0585356A1 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0341300B1 Stimulation of stem cell growth by the bryostatins |
| 03/09/1994 | CN1083524A Deletion mutants as vaccines for cholera |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/09/1994 | CN1083473A Novel compounds |
| 03/08/1994 | US5292769 Substituted mandelic acid derivatives and their use in medicaments |
| 03/08/1994 | US5292767 Treatment of autoimmune diseases |
| 03/08/1994 | US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/08/1994 | US5291896 Cardiac output probe assembly |
| 03/08/1994 | CA1327601C Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| 03/08/1994 | CA1327595C Biologically active carboxylic acid esters |
| 03/08/1994 | CA1327588C Leukotriene antagonists |
| 03/08/1994 | CA1327581C Benzopyrrolidinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 03/08/1994 | CA1327579C Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
| 03/08/1994 | CA1327570C Triazolo-thieno- and benzodiazepine derivatives as platelet activating factor antagonists |
| 03/04/1994 | CA2470670A1 Tnf ligands |
| 03/03/1994 | WO1994004691A2 Dimer and multimer forms of single chain polypeptides |
| 03/03/1994 | WO1994004680A1 Human interleukin-13 |
| 03/03/1994 | WO1994004679A1 Method for making humanized antibodies |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004540A1 27-hydroxyrapamycin and derivatives thereof |
| 03/03/1994 | WO1994004496A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004484A1 Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation |
| 03/03/1994 | WO1994004188A1 Method for treating an lfa-1-mediated disorder |
| 03/03/1994 | WO1994004180A2 Novel uses of il-4 and/or il-10, and antibodies against the same |
| 03/03/1994 | WO1994004163A1 Novel glucan preparation |
| 03/03/1994 | WO1994004160A1 Treatment of human viral infections |
| 03/03/1994 | WO1994004154A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE-NUCLEOSIDES |
| 03/03/1994 | WO1994004128A2 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions |
| 03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
| 03/03/1994 | CA2142860A1 Human interleukin-13 |
| 03/03/1994 | CA2142831A1 Treatment of human viral infections |
| 03/03/1994 | CA2142288A1 27-hydroxyrapamycin and derivatives thereof |
| 03/03/1994 | CA2140933A1 Method for treating an lfa-1 mediated disorder |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0584558A2 A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein |
| 03/02/1994 | EP0584487A2 4,5-Dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584223A1 Novel immunosuppressive compounds |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584200A1 Trifluoromethyl analogs of fucose and uses thereof |
| 03/02/1994 | EP0584185A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
| 03/02/1994 | EP0584091A1 Benzopyranones, methods of manufacture and use thereof. |
| 03/02/1994 | EP0509042B1 Pharmaceutical preparation of 1-Octadecyl-2-methyl-glycero-3-phosphocholin for intravenous administration |
| 03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
| 03/02/1994 | CN1023901C Novel family of primate hematopoietic growth factors |
| 03/02/1994 | CA2103974A1 Pyrrolidine derivatives |
| 03/01/1994 | US5290798 Antihistamines, antiallergens, antiinflammatory agents |
| 03/01/1994 | US5290797 Benzopyran compounds |
| 03/01/1994 | US5290788 Antiallergens for mammals |
| 03/01/1994 | US5290783 Use of spiperone derivatives as immunosuppressant agents |
| 03/01/1994 | US5290576 Antitumor polypeptide derivatives with iodine |
| 03/01/1994 | US5290571 Undenatured whey protein providing Vitamins B1 and B2 |
| 03/01/1994 | US5290561 Patch of room temperature vulcanizable organopolysiloxane rubber, albuterol, diffusion enhancer of normal hydrocarbon alcohol |
| 03/01/1994 | US5290554 Flowing extracting agent through bed of peat particles so that flow remains laminar |
| 03/01/1994 | CA2101599A1 Tri- and tetracyclic compounds |
| 03/01/1994 | CA1327334C Stimulation of stem cell growth by the bryostatins |
| 03/01/1994 | CA1327318C Pharmaceutical composition for the prevention and treatment of bacterial or viral diseases |
| 03/01/1994 | CA1327316C Certain paf antagonist/antihistamine combinations and methods |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/25/1994 | CA2104653A1 4,5-dihydro-4-oxo-pyrrolo [1,2-a] quinoxalinones] and corresponding aza analogs and a process for their preparation |
| 02/23/1994 | EP0584001A1 Products containing taxol for use in cancer therapy |
| 02/23/1994 | EP0583925A1 Rapamycin for the treatment of Crohn's disease, ulcerative colitis or ulcerative proctitis |
| 02/23/1994 | EP0583799A1 Monoclonal antibodies to ELAM-1 sialoglycoprotein antigen on the surface of activated endothelial cells |
| 02/23/1994 | EP0583699A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
| 02/23/1994 | EP0583698A2 Deoxycyclitol derivatives, process for their preparation and their use in medicaments |
| 02/23/1994 | EP0583360A1 Compositions for the prevention and/or treatment of pathological processes |
| 02/23/1994 | EP0583322A1 Antiserotonines, prepartion thereof and medicaments containing them |
| 02/22/1994 | US5288900 Crystallization of optical isomers of leukotriene antagonists using (R)-4-nitro-α-methylbenezenemethonamine |
| 02/22/1994 | US5288751 [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
| 02/22/1994 | US5288742 α,α dialkylbenzyl derivatives |
| 02/22/1994 | US5288733 Leukotriene synthesis inhibitors |
| 02/22/1994 | US5288730 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 02/22/1994 | CA1327204C2 Benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| 02/19/1994 | CA2104051A1 Deoxymyoinositol derivatives, process for their preparation and their use in medicaments |
| 02/19/1994 | CA2104049A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
| 02/18/1994 | CA2104042A1 Method of treating immunoinflammatory disease |
| 02/17/1994 | WO1994003603A1 Novel glycoforms of soluble complement receptor 1 |
| 02/17/1994 | WO1994003467A2 Antiretroviral enantiomeric nucleotide analogs |
| 02/17/1994 | WO1994003448A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 02/17/1994 | WO1994003440A1 Benzoxazinones as inhibitors of hiv reverse transcriptase |